Highlights based on presentations given by
Industry Experts.
|
Compiled by
Dr Usha Jain, Consultant :
Laboratory Medicine, Medical Genetics & Genomic
Science, Research Design &
Analysis, Scientific Writer
Since the onset of Covid-19
pandemic, in a short span of time, the world has
changed drastically; this pandemic has brought the in
-vitro diagnostics (IVD) industry on the forefront for
the first time. While Covid-19 has undoubtedly
presented enormous challenges, it has, however,
created several opportunities for instance, indicating
a shift in focus from China to India as the prominent
suppliers in IVD reagents and products. In line with
this perspective, on the fifth day, a webinar on the
theme “Making Innovation & Indigenization Stick: an
IVD Industry Summit” was organized. |
The meeting started with a welcome
address of all the dignitaries & participants by
Mr. D L Pandya Convenor & organizer, IMDI & Dr. Veena
Kohli, President, Association of Diagnostics
Manufacturers of India (ADMI) & CEO & Founder,
Vanguard Diagnostics (P) Ltd. being the moderator,
invited the key note speakers, Mr. Suresh Vazirani,
Chairman and Managing Director, Transasia Biomedicals
Ltd. & Dr. Jitender Sharma, Managing Director &
CEO, Andhra Pradesh MedTech Zone (AMTZ). |
|
Key Note
Address By
Mr. Suresh Vazirani
Chairman and Managing Director,
Transasia Biomedicals Limited.
Envisioning an Atma-Nirbhar IVD |
Mr. Suresh Vazirani’s key note
address entitled “Envisioning on Atma-Nirbhar IVD
Industry” highlighted the importance of IVD for every
country as diagnostics is the backbone of any
healthcare system where 70 – 80% of the treatment
decisions depend on outcome of diagnostic tests. Since
the onset of the Covid-19 pandemic, IVD has been in
real focus. The Govt has to acknowledge the tremendous
impact that IVD has made in managing the pandemic in
the Indian context, placing India at the lowest
mortality rate.
Starting from a few RT PCR to 2000
labs doing the Covid-19 diagnostic testing, where 80%
of the kits are indigenous. Sharing his 41 years of
journey in the IVD industry, when even basic tests
kits were being imported. Even today India is
importing 70% of its medical devices and less than
even 2% is being spent on healthcare. In-spite of
that, cost of diagnostics in India is the lowest in
the world providing Covid-19 testing for about one US
$. It’s unimaginable that in America its 20 US $.
The low cost of diagnostic kits is
opening a door for the Indian manufactures to export.
That’s why the Indian IVD industry is now more quality
conscious in the terms of maintaining the global
standards product quality. If it remains on the right
track, sky is the limit for Indian IVD industry.
Becoming Atma-Nirbhar is not a choice but a compulsion
for the Indian IVD industry and it needs the support
of the Govt of India to achieve its goal of becoming
50% self-reliant during the next five years. He
addressed that IVD is the toughest industry to make
money but it has a great advantage of great
satisfaction by contributing towards the healthcare of
your country and its citizens and it’s the greatest
satisfaction that no money can give. His words that by
doing so we are accumulating Good Karma too boosted
the morale of all participants and were well reflected
in discussion later with other panelists too. |
|
Key Note
Address By
Dr. Jitendra Sharma
Managing Director & CEO,
Andhra Pradesh MedTech Zone (AMTZ) |
Another key note speaker Dr.
Jitender Sharma, also known as “MEDTECH man of India”
addressed to make India Atma- Nirbhar, indigenization
and Innovation has to go hand in hand. To achieve the
same, firstly we need to reverse the flow to
diagnostic first, doctor’s consultation next and
medicine the last as presently diagnostics being the
last causes delayed diagnosis & poor management of
health. We can beat this by attaching a micro lab to a
pharmacy carrying out some basic diagnostics. When
there can be over the counter
drugs, there could be over the counter diagnostics
too. Secondly, allowing the integration of IVD into
modern commodities and thirdly, arresting the free
fall in prices in the interest of science and
innovations can truly make India Atma-Nirbhar so far
as the IVD is concerned. |
|
Panel
Discussion, Moderator
Ms. Veena Kohli
President, Association of Diagnostics Manufacturers of
India (ADMI)
& CEO & Founder, Vanguard Diagnostics (P) Limited |
Thereafter, the panel discussion
began involving Mr. Sriram Natarajan, Founder
Director & CEO, Molbio Diagnostics (P) Ltd; Dr.
Rajesh Kumar Patel, Director, Premier Medical
Corporation (P) Ltd.; Dr. Ravi Kumar Meruva,
Founder & CEO, Sensa Core Medical Instrumentation (P)
Ltd.; Mr. Sanjaymon KR, General Manager-
Business Development, Agappe
Diagnostics; Dr. Vishal Warke, Director R & D,
Hi-Media Laboratoies (P) Ltd; Dr. Manoj Chugh,
Associate Vice President R&D, Transasia Biomedicals
Ltd & Dr. D K Joshi, IPP, ADMI & Managing
Director, Beacon Diagnostics (P) Ltd., that goes as
follows: |
|
Mr. Sriram
Natarajan
Founder Director & CEO,
Molbio Diagnostics (P) Limited. |
Mr. Sriram threw light on how RT-
PCR is a common household buzz word these days since
the Covid- 19 has brought about a transformation in
the perception of diagnostics for a common man today.
He shared his strategies for tremendous success in the
innovative sector of molecular biology in India being
the main player in this industry for almost 40 years.
He shared his mission and vision to take molecular
diagnostics to the people in the remotest parts of
India. To achieve this, his company had made tireless
efforts for almost 20 years by innovating a technology
that is truly point of care RT PCR especially for the
infectious diseases where RT PCR is quick & the gold
standard. Idea of centralized lab. can delay the
reporting time & subsequently delay the treatment.
Therefore, he envisioned RT PCR at primary health care
centres, tier 2 & 3 cities. Due to this vision, today
company is serving the nation by being a part of the
National TB Control Programme. Taking high end
technology to the point of care is going to take them
to the remotest areas of the other countries too. He
shared his utmost satisfaction on this innovation by
saying “Whatever was envisioned is now taking shape”.
He was indeed applauded for his tremendous efforts &
dedication towards the democratization of molecular
testing through setting up of TRUENAT at primary
health care centres for various infectious diseases
including the Covid-19 in remotest areas of India.
In answer to another
question on the major difference between RT PCR and
the LAMP technology from IVD manufactures’ perspective
in context of the pandemic scenario, he highlighted
that though both RT PCR & RT LAMP based diagnostics
are based on the amplification of DNA.
RT PCR requires a thermal
cycler and other sophisticated accessories, while LAMP
is isothermal where reaction is being carried out in a
single tube on a simple thermal block maintaining 60 –
65 degrees. Thus, it requires no sophisticated
instrumentation, set up & skilled manpower. He
stressed that RT PCR is still the Gold Standard and as
it has evolved for over the last 40 years while the
LAMP assay has been in limelight for the last 4-5
years. Fundamentally both RT PCR and LAMP are useful
in to the IVD industry but we have to keep in mind the
end product and the end user. |
|
|
|
Advertisers' Index
|
Accuprec Research Labs Pvt. Ltd., India |
Ambica Medicare Engineering, India |
Nu-Vu Conair Pvt. Ltd., India |
Divya Steri Solutions Pvt. Ltd., India |
ET Elastomer Technik, Germany |
Eewa Engineering Co. Pvt. Ltd., India |
Ineos Styrolution India Ltd., India |
I-Kare Polyalloys Pvt. Ltd., India |
KLJ
Group, India |
Lubrizol Advanced Materials India Pvt.
Ltd. |
Kuraray India Pvt. Ltd., India |
Maider Medical Industry Equipment Ltd.China |
Medicall 2019, India |
Ferromatik Milacron India Pvt. Ltd., India |
GLR Laboratories
Pvt. Ltd., India |
Pashiba Lifescience, India |
Plastivision India |
Pradeep Surgipack, India |
PVC Colouring Compounding & Processing,
India |
Qosina,
USA |
Raumedic AG |
SMC Medical Manufacturing Pvt. Ltd.,
India |
Sterimed Medical Devices (P) Ltd., India |
Steri Techno Fab, India |
Tekni-Plex India Pvt. Ltd., India |
Twist Engineering Works,India |
Yuhuan Shengjiu Mould Co., Ltd.,
China |
Airways Surgical Pvt. Ltd., India |
Alpha Medicare and Devices Ltd., India |
Alpha Therapeutics Pvt. Ltd., India |
Ami
Polymer Pvt. Ltd., India |
Angiplast Pvt. Ltd., India |
Appasamy Associates, India |
Beacon Plastics, India |
Delux Surgical, Inida |
Ignisol Mediplas Corporation, India |
Jain Rubbers Pvt. Ltd., India |
Operon Strategist, India |
R.R. Patel Gases (P) Ltd., India |
Proven Trade Contacts, India
|
Sanidhya
Enterprise, India |
Surgi Pack India Pvt. Ltd. |
Unikal Consultants, India |
Vinit Performance Polymers Pvt. Ltd., India |
Aircity, India |
Amigo Surgi Care
Pvt. Ltd., India |
Angel Products, India |
Apex Medical Devices, India |
Jimit Medico Surgicals Pvt. Ltd. |
Kavya Packaging, India |
Life-O-Line Technologist, India |
Mesco Surgical, India |
Morrisons
Lifecare Pvt. Ltd., India |
National Healthcare, India |
Pharmadocx, Inida |
S. Nath & Co., India |
Unikal Consultants, India |
Venus
Industries,India, Mobile : 9825747495 |
Zinkal Products, India |
|